Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Uncovering the role of cardiolipin in promoting gasdermin D-mediated necroptosis and hyperinflammation

Award Number: F31AI176821
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 02/01/2024
PERIOD OF PERFORMANCE END DATE: 01/31/2025
AWARD TERMINATION DATE: 05/19/2025

Group Awards By:

View Award Description

Uncovering the role of cardiolipin in promoting gasdermin D-mediated necroptosis and hyperinflammation - PROJECT SUMMARY Mitochondria serve as a central signaling hub for innate immune responses. Disruption of mitochondrial function is a hallmark for various infections and chronic inflammatory diseases. The overall objective of this proposal is to define the molecular mechanisms that regulate mitochondrial membrane homeostasis and determine how membrane disruption promotes inflammatory cell death. Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with disrupted mitochondrial integrity and increased reactive oxygen species. They are also associated with increased susceptibility to hormonal breast cancer, Crohn's disease, and mycobacterial infection, strongly suggesting a role in innate immune function. Recently, the Watson lab set out to investigate LRRK2's role in peripheral innate immunity, focusing on a gain of function mutation, Lrrk2G2019S. Mitochondrial stress conferred by the Lrrk2G2019S mutation increases demand on the electron transport chain, which leads to excessive ROS production. This increased ROS triggers a new type of cell death where a protein canonically associated with pyroptosis, gasdermin D (GSDMD), can associate with mitochondrial membranes and cause necroptotic cell death. Aim 1 of this proposal will identify the minimal domain within GSDMD that targets mitochondrial membranes, enabling a better understanding of the molecular mechanisms underlying GSDMD's newly described role in necroptosis. Aim 2 will investigate the contribution of various aspects of mitochondrial dysfunction to GSDMD mitochondrial targeting and necroptosis, providing new insights into connections between the disruption of mitochondrial homeostasis and GSDM relocalization. With the goal of understanding how mitochondria are impacted by genetic mutations and/or stress, Aim 3 will measure relocalization of the mitochondrial inner membrane phospholipid cardiolipin in WT and Lrrk2G2019S macrophages and catalog mitochondrial lipids in WT vs. Lrrk2G2019S macrophages. Defining the molecular mechanisms that drive inflammation in the face of specific mitochondrial mutations will help enable therapeutic interventions designed to correct specific aspects of mitochondrial dysfunction associated with a variety of inflammatory, infectious, cardiac, and neurological disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2024	VANDERBILT UNIVERSITY	110 21ST AVE S	NASHVILLE	TN	37203	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	2	1/27/2026	TERMINATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	003	1	5/27/2025	NEW	$0
2025	2024	VANDERBILT UNIVERSITY	110 21ST AVE S	NASHVILLE	TN	37203	DAVIDSON	USA	Allergy and Infectious Diseases Research	001	2	12/20/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$21,926
2025	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	000	1	12/19/2024	NEW	-$21,926
2025	2024	VANDERBILT UNIVERSITY	110 21ST AVE S	NASHVILLE	TN	37203	DAVIDSON	USA	Allergy and Infectious Diseases Research	002	2	5/19/2025	TERMINATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $39,479 )
2024	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	000	1	11/30/2023	NEW	$38,199
2024	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	002	1	5/13/2024	NEW	$1,280
2024	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	001	1	11/30/2023	NEW	$0
														Subtotal = $39,479

Grand Total All Awards = $39,479

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Uncovering the role of cardiolipin in promoting gasdermin D-mediated necroptosis and hyperinflammation

Award Number: F31AI176821

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 02/01/2024

PERIOD OF PERFORMANCE END DATE: 01/31/2025

AWARD TERMINATION DATE: 05/19/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer